Photodynamic Therapy Activity of New Porphyrin-Xylan-Coated Silica Nanoparticles in Human Colorectal Cancer

Ludovic Bretin (1) , Aline Pinon (1) , Soukaina Bouramtane (1) , Catherine Ouk (2, 3) , Laurence Richard (4) , Marie-Laure Perrin (5) , Alain Chaunavel (4) , Claire Carrion (2) , Frédérique Brégier (1) , Vincent Sol (1) , Vincent Chaleix (1) , David Yannick Leger (1) , Bertrand Liagre (1)

1 PEIRENE - PEIRENE
2 CRIBL - Contrôle de la Réponse Immune B et des Lymphoproliférations
3 BISCEm - Biologie Intégrative Santé Chimie Environnement
4 Service d'Anatomie Pathologique [CHU Limoges]
5 XLIM-BIO-INGENIERIE - BIO-INGENIERIE

Photodynamic therapy (PDT) using porphyrins has been approved for treatment of several solid tumors due to the generation of cytotoxic reactive oxygen species (ROS). However, low physiological solubility and lack of selectivity towards tumor sites are the main limitations of their clinical use. Nanoparticles are able to spontaneously accumulate in solid tumors through an enhanced permeability and retention (EPR) effect due to leaky vasculature, poor lymphatic drainage, and increased vessel permeability. Herein, we proved the added value of nanoparticle vectorization on anticancer efficacy and tumor-targeting by 5-(4-hydroxyphenyl)-10,15,20-triphenylporphyrin (TPPOH). Using 80 nm silica nanoparticles (SNPs) coated with xylan-TPPOH conjugate (TPPOH-X), we first showed very significant phototoxic effects of TPPOH-X SNPs mediated by post-PDT ROS generation and stronger cell uptake in human colorectal cancer cell lines compared to free TPPOH. Additionally, we demonstrated apoptotic cell death induced by TPPOH-X SNPs-PDT and the interest of autophagy inhibition to increase anticancer efficacy. Finally, we highlighted in vivo, without toxicity, elevated anticancer efficacy of TPPOH-X SNPs through improvement of tumor-targeting compared to a free TPPOH protocol. Our work demonstrated for the first time the strong anticancer efficacy of TPPOH in vitro and in vivo and the merit of SNPs vectorization.

Mots clés: photodynamic therapy; anticancer drug; porphyrin; silica nanoparticles; drug delivery

Domaines: Cancer; Sciences pharmaceutiques

Ludovic Bretin, Aline Pinon, Soukaina Bouramtane, Catherine Ouk, Laurence Richard, et al.. Photodynamic Therapy Activity of New Porphyrin-Xylan-Coated Silica Nanoparticles in Human Colorectal Cancer. Cancers, 2019, 11 (10), pp.1474. ⟨10.3390/cancers11101474⟩. ⟨hal-02491059⟩